The effect of NO-donors on chloride efflux, intracellular Ca2+ concentration and mRNA expression of CFTR and ENaC in cystic fibrosis airway epithelial cells

Experimental and Molecular Pathology

Volumn 94, Issue 3, 2013, Pages 474-480

  Oliynyk, Igor ^a   Hussain, Rashida ^a   Amin, Ahmad ^a   Johannesson, Marie ^a,b   Roomans, Godfried M ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Airway epithelium; Calcium; CFTR; Cystic fibrosis; ENaC; Nitric oxide donors

Indexed keywords

CALCIUM; CHLORIDE; CYSTEINE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIETHYLENETRIAMINE; EPITHELIAL SODIUM CHANNEL; MESSENGER RNA; N (ETHOXYCARBONYLMETHYL) 6 METHOXYQUINOLINIU BROMIDE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CHLORIDE TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM;

BRONCHI; CALCIUM; CELL LINE; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; EPITHELIAL SODIUM CHANNELS; GENE EXPRESSION REGULATION; NITRIC OXIDE DONORS; RNA, MESSENGER; TRIAZOLES;

EID: 84876344605     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.03.003     Document Type: Article

References (46)

1. Andersson C., Gaston B., Roomans G.M. S-nitrosoglutathione induces functional DeltaF508-CFTR in airway epithelial cells. Biochemical and Biophysical Research Communications 2002, 297:552-557.
2. Balfour-Lynn I.M., Laverty A., Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Archives of Disease in Childhood 1996, 75:319-322.
3. Chao A.C., Widdicombe J.H., Verkman A.S. Chloride conductive and cotransport mechanisms in cultures of canine tracheal epithelial cells measured by an entrapped fluorescent indicator. Journal of Membrane Biology 1990, 113:193-202.
4. Chen L., Patel R.P., Teng X., Bosworth C.A., Lancaster J.R., Matalon S. Mechanisms of cystic fibrosis transmembrane conductance regulator activation by S-nitrosoglutathione. Journal of Biological Chemistry 2006, 281:9190-9199.
5. Cozens A.L., Yezzi M.J., Kunzelmann K., Ohrui T., Chin L., Eng K., Finkbeiner W.E., Widdicombe J.H., Gruenert D.C. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. American Journal of Respiratory Cell and Molecular Biology 1994, 10:38-47.
6. Dalemans W., Barbry P., Champigny G., Jallat S., Dott K., Dreyer D., Crystal R.G., Pavirani A., Lecocq J.P., Lazdunski M. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature 1991, 354:526-528.
7. Duszyk M. Regulation of anion secretion by nitric oxide in human airway epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 2001, 281:L450-L457.
8. 2+ signalling in glucose-stimulated pancreatic beta-cells. Cellular Signalling 2000, 12:781-786.
9. Elphick H.E., Demoncheaux E.A.G., Ritson S., Higenbottam T.W., Everard M.L. Exhaled nitric oxide is reduced in infants with cystic fibrosis. Thorax 2001, 56:151-152.
10. Engels K., Knauer S.K., Loibl S., Fetz V., Harter P., Schweitzer A., Fisseler-Eckhoff A., Kommoss F., Hanker L., Nekljudova V., Hermanns I., Kleinert H., Mann W., du Bois A., Stauber R.H. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Research 2008, 68:5159-5166.
11. Farinha C.M., Nogueira P., Mendes F., Penque D., Amaral M.D. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70. Biochemical Journal 2002, 366:797-806.
12. Galietta L., Folli C., Marchetti C., Romano L., Carpani D., Conese M., Zegarra-Moran O. Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-gamma. American Journal of Physiology. Lung Cellular and Molecular Physiology 2000, 278:L1186-L1194.
13. Gaston B., Singel D., Doctor A., Stamler J.S. S-nitrosothiol signaling in respiratory biology. American Journal of Respiratory and Critical Care Medicine 2006, 173:1186-1193.
14. 2+-indicator dyes. Cell Calcium 2000, 27:97-106.
15. Gomaa A.A., Elshenawy M.M., Afifi N.A., Mohammed E.A., Thabit R.H. Dual effect of nitric oxide donor on adjuvant arthritis. International Immunopharmacology 2009, 9:439-447.
16. Grasemann H. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 1999, 159:684-685.
17. Grasemann H., Drazen J.M., Yandava C.N. Protein sequence of the human neuronal nitric oxide synthase (Type I NOS): an error in the sequence database. Nitric Oxide 1997, 1:441.
18. Hardiman K.M., McNichols-Bevensee C.M., Fortenberry J., Myles C.T., Malik B., Eaton D.C., Matalon S. Regulation of amiloride-sensitive Na+ transport by basal nitric oxide. American Journal of Respiratory Cell and Molecular Biology 2004, 30:720-728.
19. Haws C.M., Nepomuceno I.B., Krouse M.E., Wakelee H., Law T., Xia Y., Nguyen H., Wine J.J. Delta F508 channels: kinetics, activation by forskolin, and potentiation by xanthines. American Journal of Physiology 1996, 270:C1540-C1555.
20. Hogg N., Singh R.J., Konorev E., Joseph J., Kalyanaraman B. S-nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochemical Journal 1997, 323:477-481.
21. + channel in human airway Calu-3 cells. American Journal of Respiratory Cell and Molecular Biology 2004, 30:388-395.
22. Jain L., Chen X.J., Brown L.A., Eaton D.C. Nitric oxide inhibits lung sodium transport through a cGMP-mediated inhibition of epithelial cation channels. American Journal of Physiology. Lung Cellular and Molecular Physiology 1998, 274:L475-L484.
23. Kamosinska B., Radomski M.W., Duszyk M., Radomski A., Man S.F. Nitric oxide activates chloride currents in human lung epithelial cells. American Journal of Physiology 1997, 272:L1098-L1104.
24. Keen C., Gustafsson P., Lindblad A., Wennergren G., Olin A.C. Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis. Pediatric Pulmonology 2010, 45:241-248.
25. Klink M., Sulowska Z. Effects of nitric oxide donors on the biological activity of human neutrophils in vitro. Letters in Drug Design & Discovery 2007, 4:55-66.
26. Kopito R.R. Biosynthesis and degradation of CFTR. Physiological Reviews 1999, 79:S167-S173.
27. + currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Letters 1997, 400:341-344.
28. Lesimple P., Beau J.M. Stereocontrolled synthesis of C-glycosides: further studies on the organolithium reagents derived from 2-deoxy-d-glucose and d-glucose. Bioorganic & Medicinal Chemistry 1994, 2:1319-1330.
29. Mall M., Grubb B.R., Harkema J.R., O'Neal W.K., Boucher R.C. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nature Medicine 2004, 10:487-493.
30. Marozkina N.V., Yemen S., Borowitz M., Liu L., Plapp M., Sun F., Islam R., Erdmann-Gilmore P., Townsend R.R., Lichti C.F., Mantri S., Clapp P.W., Randell S.H., Gaston B., Zaman K. Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:11393-11398.
31. Mendes F., Roxo Rosa M., Dragomir A., Farinha C.M., Roomans G.M., Amaral M.D., Penque D. Unusually common cystic fibrosis mutation in Portugal encodes a misprocessed protein. Biochemical and Biophysical Research Communications 2003, 311:665-671.
32. Munkonge F., Alton E.W., Andersson C., Davidson H., Dragomir A., Edelman A., Farley R., Hjelte L., McLachlan G., Stern M., Roomans G.M. Measurement of halide efflux from cultured and primary airway epithelial cells using fluorescence indicators. Journal of Cystic Fibrosis 2004, 3(Suppl. 2):171-176.
33. Nilsson H.E., Dragomir A., Lazorova L., Johannesson M., Roomans G.M. CFTR and tight junctions in cultured bronchial epithelial cells. Experimental and Molecular Pathology 2010, 88:118-127.
34. Powell K., Zeitlin P.L. Therapeutic approaches to repair defects in deltaF508 CFTR folding and cellular targeting. Advanced Drug Delivery Reviews 2002, 54:1395-1408.
35. Ramalho A.S., Beck S., Meyer M., Penque D., Cutting G.R., Amaral M.D. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. American Journal of Respiratory Cell and Molecular Biology 2002, 27:619-627.
36. Rang H.P. The receptor concept: pharmacology's big idea. British Journal of Pharmacology 2006, 147:S9-S16.
37. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1073.
38. Ruckes-Nilges C., Lindemann H., Klimek T., Glanz H., Weber W.M. Nitric oxide has no beneficial effects on ion transport defects in cystic fibrosis human nasal epithelium. Pflügers Archiv 2000, 441:133-137.
39. Servetnyk Z., Krjukova J., Gaston B., Zaman K., Hjelte L., Roomans G.M., Dragomir A. Activation of chloride transport in CF airway epithelial cell lines and primary CF nasal epithelial cells by S-nitrosoglutathione. Respiratory Research 2006, 7:124.
40. Servetnyk Z., Jiang S., Hjelte L., Gaston B., Roomans G.M., Dragomir A. The effect of S-nitrosoglutathione and l-cysteine on chloride efflux from cystic fibrosis airway epithelial cells. Experimental and Molecular Pathology 2011, 90:79-83.
41. Verkman A.S. Development and biological applications of chloride-sensitive fluorescent indicators. American Journal of Physiology 1990, 259:C375-C388.
42. Ward C.L., Omura S., Kopito R.R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 1995, 83:121-127.
43. Xia W., Szomor Z., Wang Y., Murrell G.A.C. Nitric oxide enhances collagen synthesis in cultured human tendon cells. Journal of Orthopaedic Research 2006, 24:159-172.
44. Yang Y.P., Janich S., Cohn J.A., Wilson J.M. The common variant of cystic-fibrosis transmembrane conductance regulator is recognized by Hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:9480-9484.
45. Zaman K., McPherson M., Vaughan J., Hunt J., Mendes F., Gaston B., Palmer L.A. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation. Biochemical and Biophysical Research Communications 2001, 284:65-70.
46. Zeitlin P.L. Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?. Molecular Pharmacology 2006, 70:1155-1158.